Style
YieldTurnover
Orientation
Concentrated trader| # | Security | Shares | Value | % of Portfolio |
|---|---|---|---|---|
| 1 | Kyverna Therapeutics Inc(KYTX) | 4,244,818 | $37.8M | 18.30% |
| 2 | Pyxis Oncology Inc(PYXS) | 10,024,909 | $30.2M | 14.60% |
| 3 | Taysha Gene Therapies Inc(TSHA) | 723,185 | $24.5M | 11.86% |
| 4 | Teva Pharmaceutical Inds LTD(TEVA) | 2,402,495 | $16.4M | 7.92% |
| 5 | VIR Biotechnology Inc(VIR) | 1,353,552 | $13.8M | 6.67% |
Latest filing, equity positions only
Quarter-over-quarter weight changes
| Sector | Prev % | Curr % | Change |
|---|---|---|---|
| Healthcare | 100% | 100% | 0% |
Quarter-over-quarter weight changes by market cap
| Cap Size | Prev % | Curr % | Change |
|---|---|---|---|
| Small Cap | 64.67% |
Quarter-over-quarter position changes
| 6 |
| Allogene Therapeutics Inc(ALLO) |
| 5,298,000 |
| $11.0M |
| 5.33% |
| 7 | Celldex Therapeutics Inc New(CLDX) | 279,720 | $10.4M | 5.04% |
| 8 | Editas Medicine Inc(EDIT) | 3,127,000 | $10.1M | 4.90% |
| 9 | Ultragenyx Pharmaceutical in(RARE) | 289,101 | $9.7M | 4.67% |
| 10 | Bausch Plus Lomb Corp(BLCO) | 573,472 | $9.5M | 4.60% |
| 54.77% |
| -9.9% |
| Micro Cap | 4.19% | 19.5% | +15.31% |
| Large Cap | 14.96% | 15.31% | +0.35% |
| Mid Cap | 16.18% | 10.42% | -5.76% |